Table 2. Paediatricians’ responses to the question ‘Your patient is scheduled to receive the second dose of hexavalent vaccine^a; which of the following conditions do you consider to be a contraindication?’, Italy, 2016 (n = 892) .

Condition	False contraindication		Temporary contraindication		Permanent contraindication		Don’t know		Total
Condition	n	%	n	%	n	%	n	%	Total
Severe allergic reaction to a previous dose, including anaphylaxis	26	3.0	133	15.2	693	79.1	24	2.7	876
Fever following a previous dose	831	94.6	38	4.3	7	0.8	2	0.2	878
Acute severe gastroenteritis	431	49.2	437	49.9	6	0.7	2	0.2	876
Otitis media, without fever	553	63.2	319	36.5	1	0.1	2	0.2	875
Family history of adverse reaction following a pertussis vaccine dose	717	82.2	62	7.1	40	4.6	53	6.1	872
Acute upper airway infection, without fever	629	72.0	236	27.0	8	0.9	1	0.1	874
History of pertussis	636	73.1	192	22.1	21	2.4	21	2.4	870
Diagnosis of epilepsy, well controlled	790	90.4	52	5.9	13	1.5	19	2.2	874
Fever 38–40 °C and moderate illness	67	7.7	796	91.0	10	1.1	2	0.2	875
Fever > 40 °C and severe illness	30	3.4	811	92.0	37	4.2	4	0.5	882
Congenital immunodeficiency	251	28.7	64	7.3	460	52.6	99	11.3	874

Correct responses are indicated in bold. Denominators differ for each contraindication as not all paediatricians responded to all contraindications.

^a Diphtheria, tetanus, acellular pertussis, poliomyelitis, Haemophilus influenzae type b, hepatitis B.

Table 2. Paediatricians’ responses to the question ‘Your patient is scheduled to receive the second dose of hexavalent vaccinea; which of the following conditions do you consider to be a contraindication?’, Italy, 2016 (n = 892) .